• Bassett I, Wang B, Chetty S et al. (2008) Loss to Care and Death before ART: Patients Eligible for Treatment Who Do Not Make It in Durban, South Africa. (Abstract no. 839). 5th Conference on Retroviruses and Opportunistic Infections, Boston.
  • Billy A, Mujaki J, Johnathan S et al. (2007) What Does ‘‘Lost To Follow-Up’’ Mean for Patients Enrolled in an Highly Active Antiretroviral Treatment (HAART) Programme in Africa? (Abstract no. CDB514). 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney.
  • Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
  • Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4, e5790.
  • Coetzee D, Hildebrand K, Boulle A et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18, 887895.
  • Dalal RP, Macphail C, Mqhayi M et al. (2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes 47, 101107.
  • Deribe K, Hailekiros F, Biadgilign S, Amberbir A & Beyene BK (2008) Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Tropical Medicine and International Health 13, 328333.
  • Etard JF, Ndiaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20, 11811189.
  • Ferradini L, Jeannin A, Pinoges L et al. (2006) Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367, 13351342.
  • Ive P, Conradie F, Xaba S & Sanne I (2005) Causes of Loss to Follow Up in Patients Taking Antiretroviral Therapy in the National Rollout Program of South Africa (Abstract no. MoPp0304). 3th International AIDS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro.
  • Joshi K, Jhanwar S, Mathur A, Agarwal H & Mathur SL (2008) Barriers in Adherence of ART (anti retroviral treatment): A Experience of ART Centre of Western Rajasthan, India (Abstract no. CBD0504). XVII International AIDS Conference, Mexico City.
  • Maskew M, MacPhail P, Menezes C & Rubel D (2007) Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. South African Medical Journal 97, 853857.
  • Mills EJ, Nachega JB, Buchan I et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 296, 679690.
  • Muwanga A, Easterbrook P, Schaefer P et al. (2008) Losses to follow-up in a large ART programme in Uganda. (Abstract no. 840). 15th Conference on Retroviruses and Opportunistic Infections, Boston.
  • National AIDS Commission (2008) HIV and Syphilis Sero –Survey and National HIV Prevalence and AIDS Estimates: Report for 2007. MoH, Lilongwe.
  • Spacek LA, Shihab HM, Kamya MR et al. (2006) Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clinical Infectious Diseases 42, 252259.
  • Stringer JSA, Zulu I, Levy J et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296, 782793.
  • Toure S, Kouadio B, Seyler C et al. (2008) Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS 22, 873882.
  • UNAIDS & WHO (2007) AIDS Epidemic Update. WHO, Geneva.
  • Weiser S, Wolfe W, Bangsberg D et al. (2003) Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndromes 34, 281288.
  • WHO & UNAIDS (2003) Treating 3 Million by 2005: Making it Happen: The WHO and UNAIDS Global Initiative to Provide Antiretroviral Therapy to 3 Million People with HIV/AIDS in Developing Countries by the end of 2005. WHO, Geneva.
  • WHO, UNAIDS & UNICEF (2009) Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. Progress report July 2008. WHO, Geneva.
  • Yu J, Chen S, Wang K et al. (2007) True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bulletin of the World Health Organization 7, 550554.